Literature DB >> 19027868

Interplay between keratinocytes and immune cells--recent insights into psoriasis pathogenesis.

Giulia Tonel1, Curdin Conrad.   

Abstract

Psoriasis is one of the most common human inflammatory skin diseases characterised by hyperproliferation and aberrant differentiation of keratinocytes. The trigger of the typical epidermal changes seen in psoriasis was considered to be a dysregulated immune response with Th-1/Tc1 cells playing a central role. Recent studies have provided new insights into psoriasis pathogenesis in defining intraepidermal alpha(1)beta(1)+ T cells as key effectors driving keratinocyte changes. Critical roles for IFN-alpha secreted by plasmacytoid dendritic cells and the IL-23/Th-17 axis were postulated. Initially, these subsequent stages are at least partially driven by the endogenous antimicrobial peptide LL37 that converts inert self-DNA into a potent trigger of interferon production by binding and delivering the DNA into plasmacytoid dendritic cells to trigger toll-like receptor 9. As LL37 is expressed by keratinocytes upon various stimuli, keratinocytes might regain momentum as instigators of an aberrant immune response which then precedes the characteristic changes in the epidermis. Data from these new studies indicate a complex interplay between keratinocytes overexpressing antimicrobial peptides and immune cells driving epidermal hyperproliferation and aberrant keratinocyte differentiation in the pathogenesis of psoriasis.

Entities:  

Mesh:

Year:  2008        PMID: 19027868     DOI: 10.1016/j.biocel.2008.10.022

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  30 in total

1.  miR-320b Is Down-Regulated in Psoriasis and Modulates Keratinocyte Proliferation by Targeting AKT3.

Authors:  Yan Wang; Xiaojing Yu; Lihua Wang; Weiyuan Ma; Qing Sun
Journal:  Inflammation       Date:  2018-12       Impact factor: 4.092

2.  Epidermal ablation of Dlx3 is linked to IL-17-associated skin inflammation.

Authors:  Joonsung Hwang; Ryosuke Kita; Hyouk-Soo Kwon; Eung Ho Choi; Seung Hun Lee; Mark C Udey; Maria I Morasso
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

Review 3.  Monoclonal antibodies inhibiting IL-12, -23, and -17 for the treatment of psoriasis.

Authors:  Caleb Jeon; Sahil Sekhon; Di Yan; Ladan Afifi; Mio Nakamura; Tina Bhutani
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

4.  Association between psoriasis and incident cancer: the Iowa's Women's Health Study.

Authors:  Anna E Prizment; Alvaro Alonso; Aaron R Folsom; Rehana L Ahmed; Beth A Virnig; Erin M Warshaw; Kristin E Anderson
Journal:  Cancer Causes Control       Date:  2011-05-07       Impact factor: 2.506

5.  Abnormal aquaporin-3 protein expression in hyperproliferative skin disorders.

Authors:  Kristen E Voss; Roni J Bollag; Nicole Fussell; Charya By; Daniel J Sheehan; Wendy B Bollag
Journal:  Arch Dermatol Res       Date:  2011-03-13       Impact factor: 3.017

Review 6.  Roles of microRNAs in psoriasis: Immunological functions and potential biomarkers.

Authors:  Qing Liu; Ding-Hong Wu; Ling Han; Jing-Wen Deng; Li Zhou; Rui He; Chuan-Jian Lu; Qing-Sheng Mi
Journal:  Exp Dermatol       Date:  2017-03-01       Impact factor: 3.960

Review 7.  Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases.

Authors:  Merouane Bencherif; Patrick M Lippiello; Rudolf Lucas; Mario B Marrero
Journal:  Cell Mol Life Sci       Date:  2010-10-15       Impact factor: 9.261

8.  Serum amyloid A, an acute phase protein, stimulates proliferative and proinflammatory responses of keratinocytes.

Authors:  Ning Yu; Shujie Zhang; Jiajing Lu; Ying Li; Xuemei Yi; Li Tang; Lina Su; Yangfeng Ding
Journal:  Cell Prolif       Date:  2016-12-02       Impact factor: 6.831

Review 9.  Psoriasis: from Pathogenesis to Targeted Therapies.

Authors:  Curdin Conrad; Michel Gilliet
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

10.  Interleukin-17 and Interleukin-22 Induced Proinflammatory Cytokine Production in Keratinocytes via Inhibitor of Nuclear Factor κB Kinase-α Expression.

Authors:  Kyung-Ah Cho; Jin-Young Kim; So-Youn Woo; Hyun Jeong Park; Kyung Ho Lee; Chi-Un Pae
Journal:  Ann Dermatol       Date:  2012-11-08       Impact factor: 1.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.